CJC-1295 (no DAC)

Short-acting GHRH receptor agonist

99.19% HPLC-MSBatch PH-4204 In stock

$65per 5 mg vial

Vial strength

View purity report (COA)Ships in 1 business day

Short GHRH analogue intended to resist degradation without albumin binding. Produces a brief GHRH receptor signal and is promoted to preserve pulsatile GH release.

Specifications

Compound class: Short-acting GHRH receptor agonist
Sequence: Tetrasubstituted GHRH(1-29) without DAC
Chain length: 29 aa
Physical form: Lyophilized powder
Modifications: Protease-resistant substitutions; no albumin-reactive DAC
Reported half-life: Short, generally described in minutes rather than days; exact marketed-product PK unverified
Verified purity: 99.19% (HPLC-MS)
Evidence grade: E4 — Mechanistic / early human

Read the full monograph in the Peptide Atlas

Research use only. All products sold on this website are intended for laboratory research and in-vitro experimentation only. They are not drugs, foods, cosmetics, or medical devices, and are not intended to diagnose, treat, cure, or prevent any disease. Nothing on this site should be construed as medical advice, dosing, or administration guidance. Purchasers must be qualified researchers or institutions and are solely responsible for lawful handling and use.